Close
  Indian J Med Microbiol
 

Figure 1: BCR-free survival among all patients. (a) BCR-free survival by prostate-specific antigen level at diagnosis; (b) BCR-free survival by pathological Gleason grade group; (c) BCR-free survival by pathological T stage; (d) BCR-free survival by pathological N stage; (e) BCR-free survival by NCCN risk group; (f) BCR-free survival by surgical margins. NCCN: National Comprehensive Cancer Network; BCR: Biochemical recurrence.

Figure 1: BCR-free survival among all patients. (<b>a</b>) BCR-free survival by prostate-specific antigen level at diagnosis; (<b>b</b>) BCR-free survival by pathological Gleason grade group; (<b>c</b>) BCR-free survival by pathological T stage; (<b>d</b>) BCR-free survival by pathological N stage; (<b>e</b>) BCR-free survival by NCCN risk group; (<b>f</b>) BCR-free survival by surgical margins. NCCN: National Comprehensive Cancer Network; BCR: Biochemical recurrence.